Access cutting-edge blood cancer treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Access blood cancer specialists in Omaha at no cost
This study follows strict safety protocols and ethical guidelines
All study-related blood cancer treatment provided free
A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk Myelodysplastic syndrome.
Sponsor: CellCentric Ltd.
Check if you qualify for this blood cancer clinical trial in Omaha, NE
If you're searching for blood cancer treatment options in Omaha, NE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced blood cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.